Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 12,043

Document Document Title
WO/2012/073214A4
Compounds having the general formula (I) pharmaceutical compositions containing them for use in inhibiting bacterial heptose biosynthesis and thereby lowering or suppressing bacterial virulence.  
WO/2012/073214A2
Compounds having the general formula (I) and their biological applications.  
WO/2012/071371A2
The disclosure relates to labeling glycans and glycosphingolipids from undefined mixtures with chemical moieties that emit light when exposed to electromagnetic radiation and uses of these labeled glycans and glycosphingolipids in microa...  
WO/2012/071371A3
The disclosure relates to labeling glycans and glycosphingolipids from undefined mixtures with chemical moieties that emit light when exposed to electromagnetic radiation and uses of these labeled glycans and glycosphingolipids in microa...  
WO/2012/069730A1
The invention relates to a compound having Formula (I), nC7-H15-O-(G)p-H (I), where G is the residue of a reducing sugar, and p is a decimal number greater than or equal to 1.05 and less than or equal to 5. The invention also relates to ...  
WO/2012/071508A1
A method of preparing a ribofuranose derivative essentially free of pyranose compounds includes a step of contacting a solution of MDR containing MDRP as an impurity in a solvent including methanol and/or tetrahydrofuran with at least on...  
WO/2012/066949A1
Radish is a plant highly valuable as a food material. The purpose of the present invention is to provide a glucoraphanin-rich radish plant at a low cost using neither a chemical treatment nor a transgenic treatment, said glucoraphanin ha...  
WO/2012/068457A1
The invention relates to the use of adsorb/desorb chromatography to prepare enriched compositions comprising rebaudioside B and/or rebaudioside D. Compositions with enriched rebaudioside-B and/or rebaudioside-D components may be prepared...  
WO/2012/067978A1
Compounds having antibacterial activity are disclosed. The compounds have a structure including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein Q1 and Q2 are as defined herein. Methods associated with prepa...  
WO/2012/062996A1
The invention relates to compounds of formula (I) where: R1 ≠ 2-deoxystreptamine and the derivatives thereof substituted in positions 5 and/or 6; R2 and R6 are the same or different and represent a primary, secondary or tertiary amine ...  
WO/2012/065054A1
A compound, or a pharmaceutically acceptable salt, ester, hydrate or solvate thereof, comprising formula I: A-B wherein A comprises a carbohydrate that is a neuraminidase or galactosidase substrate; B comprises an odorant moiety; B is co...  
WO/2012/061662A9
Compounds, compositions and methods are provided for treating cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of the cells i...  
WO/2012/061662A1
Compounds, compositions and methods are provided for treating cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of the cells i...  
WO/2012/055010A1
The present document describes a neutraceutical, cosmeceuticals, functional food, pharmaceutical, food ingredient, and non-food ingredient compositions comprising sugar maple extract, essential oil compositions comprising oil extracted f...  
WO/2012/052596A1
The invention relates to novel inhibitors of tumour cell division. These inhibitors are semi-synthetic derivatives of neurostatin. The invention also relates to a novel method for the synthesis of the inhibitors and neurostatin. In addit...  
WO/2012/052843A1
The present invention includes novel derivatives, analogs, and intermediates of the natural products radicicol, pochonins, pochoximes, and their syntheses. The present invention also provides a pharamceutical composition comprising the p...  
WO/2012/049437A3
The invention relates to a method for transforming iota-carrageenan into alpha-carrageenan by means of a new class of 4S-iota-carrageenan sulfatase. The invention can be especially applied to the agro-food, pharmaceutical and cosmetic in...  
WO/2012/049437A2
The invention relates to a method for transforming iota-carrageenan into alpha-carrageenan by means of a new class of 4S-iota-carrageenan sulfatase. The invention also relates to carrageenans obtained by said conversion method. The inven...  
WO/2012/048119A2
The present invention provides polyphenolic compositions derived from a plant that inhibit the formation of a biofilm. Also provided are combinations that comprise at least one phenolic phytochemical and at least one antimicrobial agent ...  
WO/2012/047763A2
Flavonoid glycosides, such as isoquercitrin, are shown to stimulate the formation of neuritis and neuronal synapses in neurons and neuronal progenitor (stem) cells.  
WO/2012/045363A1
There is provided an antidiabetic enolic glucoside of phenylpyruvic acid and derivatives thereof for use as medicaments, especially normoglycemic agents, i.e. for lowering blood glucose levels to normal levels in mammals that are obese, ...  
WO/2012/042508A1
A commercially viable method is provided herein for isolating and purifying steviol glycosides from a source containing said steviol glycosides The method includes the first step of passing an organic solution containing said steviol gly...  
WO/2012/037034A1
Compounds, compositions and methods are provided for inhibiting in vitro and in vivo processes mediated by E-selectin binding. More specifically, particular glycomimetic compounds are described, wherein the compounds are E- selectin anta...  
WO/2012/021981A1
The present invention describes phytochemicals present in maple syrup and maple tree extracts by butanol, ethyl acetate and methanol. Novel compounds are isolated from maple syrups, including one compound Quebecol generated in the maple ...  
WO/2012/017199A1
Compounds of Formula (1) isolated from Bacillus spp. that act as colouring agents and/or antioxidants for use in foodstuffs and animal feed, wherein X is independently selected from methyl and COOR wherein R is independently selected fro...  
WO/2012/016994A1
The present invention relates to novel bisphosphonate duplex drugs, methods for preparing said compound; pharmaceutical compositions containing the same; as well as the use of said compounds in human and veterinary medicine, and, in part...  
WO/2012/012339A2
The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug analogs of the analgesic acetaminophen. This invention relates to a method for the production of a broad group of glycosides of ...  
WO/2012/006742A9
A simple extraction method for preparing an organic certifiable stevia extract with high sweetness and optionally with antioxidant properties is provided. The extraction method involves extraction of stevia leaves that have been dried an...  
WO/2012/007585A9
The invention relates to a method for purifying, separating and/or isolating an oligosaccharide of general formula 1 or a salt thereof (general formula 1) wherein R1 is fucosyl or H, R2 is fucosyl or H, R3 is selected from H, sialyl, N-a...  
WO/2012/006742A1
A simple extraction method for preparing an organic certifiable stevia extract with high sweetness and optionally with antioxidant properties is provided. The extraction method involves extraction of stevia leaves that have been dried an...  
WO/2012/007585A1
The invention relates to a method for purifying, separating and/or isolating an oligosaccharide of general formula 1 or a salt thereof (general formula 1) wherein R1 is fucosyl or H, R2 is fucosyl or H, R3 is selected from H, sialyl, N-a...  
WO/2012/004684A3
Guanadinylated aminoglycoside-lipid conjugates are prepared. Such conjugates may comprise an aminoglycoside such as an aminoglyucoside antibiotic like neomycin or kanamycin, at least one guanidino group attached to a primary or secondary...  
WO/2011/153815A1
N-acyl modified sialic acid (α-(2→6)-D-aminopyranose derivatives, their synthesis methods and uses are disclosed. Sialic acid (α-(2→6)-D-aminopyranose derivatives represented by formula (I) are synthesized by using D-aminogalactose...  
WO/2011/154452A1
New low molecular weight complexes between iron and maltobionic acid that can be administered parenterally, preferably intramuscularly or subcutaneously, in the treatment of anemic states, caused by iron deficiencies, and new pharmaceuti...  
WO/2011/155687A1
The present invention provides a novel glycolipid derivative compound, a composition for inhibiting vascular smooth muscle cell proliferation using the same and a composition a hyper-proliferative disease of vascular smooth muscle cells ...  
WO/2011/145068A1
The present invention relates to a compound of general formula (I) in which: - X is OH, NH2, NHOH or RNH, wherein R may be a linear or branched, saturated or unsaturated, C1-C10 alkyl radical, - Y is H, or an electron-withdrawing group, ...  
WO/2011/145519A1
Disclosed are methods for producing a glucoside directly from glucose or a sugar chain comprising glucose as a structural unit. Specifically disclosed are: a method which comprises reacting glucose or a sugar chain comprising glucose as ...  
WO/2011/143497A1
The present invention relates to antimicrobial and antibiotic aminoglycoside derivatives. The compounds of the present application have the following chemical structures. The invention also relates to compositions, methods of preparation...  
WO/2011/138365A1
A process for the preparation of 1,6-Bis-[3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosylo xy)-phenyl] hexane (I) which comprises the steps of converting the compound (2'-Methoxy-biphenyl-3-yl)-acetic acid (A) into the (2'-Methoxy-bip...  
WO/2011/137181A1
The present invention provides synthetic Moraxella catarrhalis lipooligosaccharide (LOS)-based oligosaccharides and conjugates containing various M. catarrhalis serotype-specific oligosaccharide antigens or various core M. catarrhalis ol...  
WO/2011/137181A8
The present invention provides synthetic Moraxella catarrhalis lipooligosaccharide (LOS)-based oligosaccharides and conjugates containing various M. catarrhalis serotype-specific oligosaccharide antigens or various core M. catarrhalis ol...  
WO/2011/133227A2
The present invention synthetic oligo-β-(1→6)-glucosamine structures and a methodology which essentially allows for the synthesis of any oligo-β-(1→6)- glucosamine species having a definite number of monosaccharide units, including...  
WO/2011/133227A3
The present invention synthetic oligo-β-(1→6)-glucosamine structures and a methodology which essentially allows for the synthesis of any oligo-β-(1→6)- glucosamine species having a definite number of monosaccharide units, including...  
WO/2011/125057A4
The invention relates to novel eucomic acid (2-(4-hydroxybenzyl)malic acid) derivatives or plant extracts comprising such derivatives, and also to cosmetic or dermatological compositions containing these compounds or these extracts, and ...  
WO/2011/125057A1
The invention relates to novel eucomic acid (2-(4-hydroxybenzyl)malic acid) derivatives or plant extracts comprising such derivatives, and also to cosmetic or dermatological compositions containing these compounds or these extracts, and ...  
WO/2011/124986A3
In some aspects, the present invention provides aminoglycoside derivatives thereof that exhibit antibacterial activity. In some aspects, the aminoglycoside derivatives comprise compounds consisting of (a) an ammoglycoside group and (b) a...  
WO/2011/127179A1
Compounds, compositions and methods are provided for use to inhibit infection by human immunodeficiency virus (HIV). More specifically, the present invention relates to glycomimetic compounds that inhibit HIV infection, and uses thereof.  
WO/2011/118929A3
The present invention relates to the crystal form of Epirubicin hydrochloride stable against heat and water and the preparation method thereof. The novel crystal form has the physiochemical property stable against heat and water accordin...  
WO/2011/118929A2
The present invention relates to the crystal form of Epirubicin hydrochloride stable against heat and water and the preparation method thereof. The novel crystal form has the physiochemical property stable against heat and water accordin...  
WO/2011/113373A1
Disclosed is a method for ultrasonic extraction of stevioside. Crushed dry leaves of Stevia rebaudiana serve as raw material. Based on the characteristic that an ultrasonic cavitation can reinforce the extraction of active ingredients in...  

Matches 351 - 400 out of 12,043